Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Tarnow

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|October 13, 2011
Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathyS Theilade, M Lajer, A Jorsal, et al.
Diabetologia|December 24, 2004
Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathyL Tarnow, P Hildebrandt, B V Hansen, et al.
Diabetes Care|November 1, 1994
Prevalence of arterial hypertension in diabetic patients before and after the JNC-VL Tarnow, P Rossing, M A Gall, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 15, 2012
Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetesS Theilade, M Lajer, A Jorsal, et al.
Diabetologia|April 4, 2008
Long-term prevention of diabetic nephropathy: an auditK J Schjoedt, H P Hansen, L Tarnow, et al.
Diabetologia|August 29, 2006
Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetesL Tarnow, M-A Gall, B V Hansen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 23, 2006
Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathyK J Schjoedt, M Lajer, S Andersen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1997
Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathyJ W Chen, P M Hansen, L Tarnow, et al.
Diabetologia|August 23, 2008
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathyA Jorsal, L Tarnow, A Flyvbjerg, et al.
Diabetes Care|March 31, 1999
Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathyL Tarnow, A Sato, S Ali, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Diabetic Medicine : a Journal of the British Diabetic Association|October 13, 2011
Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathyS Theilade, M Lajer, A Jorsal, et al.
Diabetologia|December 24, 2004
Plasma N-terminal pro-brain natriuretic peptide as an independent predictor of mortality in diabetic nephropathyL Tarnow, P Hildebrandt, B V Hansen, et al.
Diabetes Care|November 1, 1994
Prevalence of arterial hypertension in diabetic patients before and after the JNC-VL Tarnow, P Rossing, M A Gall, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 15, 2012
Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetesS Theilade, M Lajer, A Jorsal, et al.
Diabetologia|April 4, 2008
Long-term prevention of diabetic nephropathy: an auditK J Schjoedt, H P Hansen, L Tarnow, et al.
Diabetologia|August 29, 2006
Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetesL Tarnow, M-A Gall, B V Hansen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 23, 2006
Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathyK J Schjoedt, M Lajer, S Andersen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 1, 1997
Genetic variation of a collagen IV alpha 1-chain gene polymorphism in Danish insulin-dependent diabetes mellitus (IDDM) patients: lack of association to nephropathy and proliferative retinopathyJ W Chen, P M Hansen, L Tarnow, et al.
Diabetologia|August 23, 2008
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathyA Jorsal, L Tarnow, A Flyvbjerg, et al.
Diabetes Care|March 31, 1999
Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathyL Tarnow, A Sato, S Ali, et al.
Pageof 11